Tag Medicare

Uncategorized

Eli Lilly’s Latest Moves: Wider Medicare Access for GLP-1 Drugs and a Leukemia Treatment Breakthrough

Blue GLP-1 injection pens used for treating type 2 diabetes and obesity.

Eli Lilly had a busy few weeks. The company closed its first quarter of 2026 with strong numbers. But the real story goes beyond earnings. Two separate developments deserve attention, and they touch very different corners of medicine. First, there’s…

Adeeba
July 5, 2026

News

Eli Lilly’s GLP-1 Drugs Are About to Get Easier to Afford Through Medicare

Eli Lilly just posted numbers that turned heads across the pharmaceutical industry. The company brought in $19.8 billion in revenue for the first quarter of fiscal 2026. That’s a 56 percent jump from last year. Two drugs drove much of…

Adeeba
July 2, 2026

News

Medicare Will Now Cover Weight Loss Drugs Like Wegovy and Zepbound, But Only for 18 Months

Close-up of a Medicare card on official documents with a purple paper clip, representing U.S. health insurance coverage.

Millions of older Americans just got a new option for tackling obesity. It comes with a price tag most people can actually afford. Starting July 1, 2026, Medicare will cover certain GLP-1 weight loss drugs through a new program called…

Adeeba
July 1, 2026